CNW/ - Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for ...
Cohort studies like Framingham and Bogalusa have been pivotal in identifying cardiovascular risk factors and understanding early-life exposures' long-term impact. The meeting included new evidence and ...
The TO_AITION project, completed this month (December 2025), has been investigating the biological causes of inflammation ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback